Home › Alzheimer's Disease › Massachusetts › Newton
Alzheimer's Disease clinical trials in Newton, MA
12 studies for Alzheimer's Disease are looking for participants at sites in and around Newton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
RecruitingPhase 3
- Boston Center for Memory, Newton
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
RecruitingPhase 4
- Adams Clinical - Watertown, Watertown · 3 mi away
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
RecruitingPhase 2
- Boston Center for Memory - Newton- Site Number : 8400007, Newton
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
RecruitingPhase 2
- Adams Clinical Watertown, Watertown · 3 mi away
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RecruitingPhase 3
- Boston Center for Memory, Newton
- Adams Clinical Watertown, Watertown · 3 mi away
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
RecruitingPhase 1/2
- Adams Clinical /ID# 277754, Watertown · 3 mi away
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RecruitingPhase 3
- Local Institution - 0080, Watertown · 3 mi away
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
RecruitingPhase 3
- Boston Center for Memory, Newton
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
RecruitingPhase 2
- Boston Center for Memory ( Site 1008), Newton
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- Boston Center for Memory, Newton
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RecruitingPhase 3
- Boston Center for Memory, Newton
- MedVadis Research Corporation, Waltham · 3 mi away
Triage Survey for Neurology Research Eligibility
RecruitingObservational studyHealthy volunteers welcome
- Adams Clinical, Watertown · 3 mi away
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- Philadelphia, PA15 studies
- The Villages, FL15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
Other studies in Newton
- Major Depressive Disorder10 studies
- Obesity9 studies
- Depression7 studies
- Overweight6 studies
- Psoriasis6 studies
- Non-Small Cell Lung Cancer5 studies
- Chronic Pain4 studies
- Breast Cancer4 studies
- Schizophrenia4 studies
- Mild Cognitive Impairment4 studies
- Atopic Dermatitis (Eczema)4 studies
- Ulcerative Colitis4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.